Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
FL.4.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FR.1.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FU.2.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.16.10NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBL.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.24.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FY.1.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.2.3.5NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.9.5NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FE.1.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.16.13NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FR.1.4NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FY.5NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FY.1.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.2.3.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FE.1.1.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FY.6NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
EG.1.6NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FL.1.1.1NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
XBB.1.16.30NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
HH.2NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
HK.29NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FY.3.3NWon-NGTTGCGACTACGTGATGAGG20552884928830R-23088.1South Korea
FY.5NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
FY.1.2NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
XBB.2.3.3NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
FE.1.1.3NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
FY.6NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
EG.1.6NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
FL.1.1.1NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
XBB.1.16.30NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
HH.2NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
HK.29NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
FY.3.3NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
XBB.2.3.8NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
FL.24NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
XBB.2.3.20NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
EG.5.2.2NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
HK.27NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
HK.30NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
HK.1NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
EG.5.1.17NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
DV.6.2NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
FK.1.1NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
HH.7NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
XBB.1.22.2NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
GY.6NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
HW.1.3NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
FY.2NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
XBB.1.5.38NHKU-NTAATCAGACAAGGAACTGATTA2231.822914529166F-18800.2Hong Kong
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used